IP Library Granted Patent US 9,109,252
Granted Patent B2
US 9,109,252 · App. 14/128,107 · Granted Aug 18, 2015

Identity elucidation of unknown metabolites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,109,252
App. No.
14/128,107
Granted
Aug 18, 2015
Kind
B2
Abstract

A method of elucidating the identity of an unknown metabolite comprising measuring amounts of known and unknown metabolites in subjects; associating the unknown metabolite with a specific gene from a gene association study; determining a protein associated with the specific gene and analyzing information for the protein; associating the unknown metabolite with concentrations and/or ratios of other metabolites in subjects; obtaining chemical structural data for the unknown metabolite; and using the information obtained to elucidate the identity of the unknown metabolite.

Claims (37)

1. A method of determining the structure of an unknown metabolite when the accurate mass of the metabolite is known, comprising:

(a) measuring amounts of known and unknown metabolites in subjects;

(b) associating an unknown metabolite with a specific gene using a genome wide association study;

(c) determining a protein associated with the specific gene and analyzing information for the protein;

(d) associating the unknown metabolite with concentrations and/or ratios of other metabolites in the subjects using a partial correlation network;

(e) obtaining chemical structural data for the unknown metabolite using a mass spectrometer; and

(f) correlating the results obtained from steps (a) through (e) to determine the structure of the unknown metabolite.

2. The method of claim 1 , wherein the specific gene comprises a genetic polymorphism.

3. The method of claim 1 , further comprising reviewing the structure and/or characteristics of other metabolites associated with the specific gene from the genome wide association study and/or identifying the biochemical pathway with which at least a portion of the other metabolites associated with the specific gene are involved prior to performing step (f).

4. The method of claim 1 , further comprising reviewing the structure and/or characteristics of the other metabolites associated with the unknown metabolite using the partial correlation network and/or identifying the biochemical pathway with which at least a portion of the other metabolites are involved prior to performing step (f).

5. The method of claim 1 , wherein the mass spectrometric data of the unknown metabolite comprises mass, molecular formula, or fragmentation spectra.

6. The method of claim 1 , wherein the information concerning the protein known to be associated with the gene includes function of the protein.

7. The method of claim 1 , wherein the protein performs a metabolic function.

8. The method of claim 1 , wherein the protein is an enzyme.

9. The method of claim 8 , wherein the substrate of the enzyme is identified.

10. The method of claim 9 , wherein the information includes the biochemical pathway for the substrate.

11. The method of claim 9 , wherein the information includes alternative biochemical pathways for the substrate.

12. The method of claim 8 , wherein an alternative substrate of the enzyme is determined.

13. The method of claim 12 , wherein the information includes the biochemical pathway for the substrate.

14. The method of claim 1 , wherein the protein is a transporter.

15. The method of claim 3 , wherein reviewing the structure and/or characteristics of the other metabolites associated with the specific gene from the genome wide association study and/or metabolites associated using the partial correlation network includes reviewing mass, class of compound, retention time, isotope patterns, fragments, and functionality of the other metabolites.

16. The method of claim 1 , wherein the association between the protein and the specific gene is the protein being encoded by the gene.

17. A method of determining the structure of an unknown metabolite when the accurate mass of the metabolite is known, comprising:

(a) measuring amounts of known and unknown metabolites in subjects;

(b) associating an unknown metabolite with a specific gene from a genome wide association study;

(c) determining a protein associated with the specific gene and analyzing information for the protein;

(d) reviewing the structure and/or characteristics of other metabolites associated with the specific gene from the genome wide association study;

and/or identifying the biochemical pathway with which at least a portion of the other metabolites associated with the specific gene are involved;

(e) obtaining chemical structural data for the unknown metabolite using a mass spectrometer; and

(f) correlating results obtained from steps (a) through (e) to determine the structure of the unknown metabolite.

18. A method of determining the structure of an unknown metabolite when the accurate mass of the metabolite is known, comprising:

(a) measuring amounts of known and unknown metabolites in subjects;

(b) associating an unknown metabolite with concentrations and/or ratios of other metabolites in the subjects using a partial correlation network;

(c) reviewing the structure and/or characteristics of the other metabolites associated with the unknown metabolite; and/or identifying the biochemical pathway with which at least a portion of the other metabolites associated with the unknown metabolite are involved;

(d) obtaining chemical structural data for the unknown metabolite using a mass spectrometer; and

(e) correlating the results obtained from steps (a) through (d) to determine the structure of the unknown metabolite.

19. The method of claim 18 , further comprising associating the unknown metabolite with a specific gene from a genome wide association study and determining a protein associated with the specific gene and analyzing information for the protein.

Assignments (11)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM " PERCEPTIVE CREDIT HOLDINGS ILL, LP" TO "PERCEPTIVE CREDIT HOLDINGS III, LP" PREVIOUSLY RECORDED AT REEL: 66971 FRAME: 0054. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Apr 4, 2024
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: METABOLON, INC.
Reel/Frame 067019/0662 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2024
From: PERCEPTIVE CREDIT HOLDINGS ILL, LP
To: METABOLON, INC.
Reel/Frame 066971/0054 →
SECURITY AGREEMENT Recorded Jul 24, 2020
From: METABOLON, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 053313/0406 →
RELEASE OF SECURITY INTEREST Recorded Jul 23, 2020
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: METABOLON, INC.
Reel/Frame 053290/0441 →
SECURITY INTEREST Recorded Jun 10, 2020
From: METABOLON, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 052902/0736 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0568 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0658 →
SECURITY INTEREST (TERM LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0396 →
SECURITY INTEREST (REVOLVING LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2014
From: KASTENMUELLER, GABRIELE; KRUMSIEK, JAN; SUHRE, KARSTEN
To: HELMHOLTZ ZENTRUM MUNCHEN
Reel/Frame 032475/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2014
From: MILBURN, MICHAEL
To: METABOLON, INC.
Reel/Frame 032475/0548 →